For non-exempt studies, the IRB must review and approve all recruitment materials (e.g., emails, flyers, social media ads, radio/newspaper ads etc.), and approve them before they are used.  

If advertising for participants, investigators must follow these guidelines:

• Information must not be misleading to subjects, especially when a study will involve vulnerable populations
• Include the name and address of the investigator, the purpose of the research and eligibility criteria for participation as subjects, a clear description of any benefits and/or risks of participating, the affiliation of the researcher, the location of the research, and whom to contact for further information
• If a drug, device and/or novel procedure/product is being studied in the research and the impact of it is still being evaluated, no claim should be made as to its superiority, safety or effectiveness. 
• Avoid overemphasis on payments (e.g., not larger/bold font than other text, no details about payments without any context about what the study will entail and/or the time commitment needed for participation)
• A copy of all recruitment materials must be included in the Research Administration Portal (RAP) for all non-exempt studies.